We are live on ! Find out more
ALT icon

Altimmune
ALT

37 hedge funds and large institutions have $37M invested in Altimmune in 2013 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,140,300% more call options, than puts

Call options by funds: $21.4M | Put options by funds: $1K

0% more funds holding

Funds holding: 37 → 37 (0)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

0% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 9

7% less capital invested

Capital invested by funds: $39.9M → $37M (-$2.92M)

Holders
37
Holders Change
–
Holders Change %
0%
% of All Funds
1.07%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
5
Increased
9
Reduced
9
Closed
5
Calls
$21.4M
Puts
$1K
Net Calls
+$21.4M
Net Calls Change
+$15.5M

Top Buyers

1
JCI
Jet Capital Investors
New York
+$421K
2
SC
Sophrosyne Capital
New York
+$386K
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$220K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$97.9K
5
U
UBS
Switzerland
+$89.5K

Top Sellers

1
Deutsche Bank
Deutsche Bank
Germany
-$280K
2
Renaissance Technologies
Renaissance Technologies
New York
-$211K
3
PCM
Perkins Capital Management
Minnesota
-$70.4K
4
FCH
Freestone Capital Holdings
Washington
-$56K
5
VKH
Virtu KCG Holdings
New York
-$51K
Name Holding Trade Value Shares
Change 		Change in
Stake
MAM
1
MPM Asset Management
Massachusetts
$11.8M – – –
PGCM
2
Prescott Group Capital Management
Oklahoma
$9.76M – – –
OTPPB
3
Ontario Teachers' Pension Plan Board
Ontario, Canada
$2.83M – – –
PCM
4
Perkins Capital Management
Minnesota
$2.82M -$70.4K -118 -2%
JCI
5
Jet Capital Investors
New York
$2.28M +$421K +706 +21%
Vanguard Group
6
Vanguard Group
Pennsylvania
$2.13M +$97.9K +164 +4%
GMCM
7
Gruber & McBaine Capital Management
California
$1.12M – – –
PCM
8
Potomac Capital Management
New York
$1.05M +$1.12M +1,885 New
BCM
9
Bridgeway Capital Management
Texas
$468K – – –
SC
10
Sophrosyne Capital
New York
$362K +$386K +647 New
Geode Capital Management
11
Geode Capital Management
Massachusetts
$324K – – –
BFA
12
BlackRock Fund Advisors
California
$251K +$11.3K +19 +4%
OAM
13
Oxford Asset Management
United Kingdom
$248K – – –
California Public Employees Retirement System
14
California Public Employees Retirement System
California
$214K – – –
Fidelity Investments
15
Fidelity Investments
Massachusetts
$205K +$220K +368 New
BIT
16
BlackRock Institutional Trust
California
$174K +$38.8K +65 +26%
JGC
17
J. Goldman & Co
New York
$163K +$28.6K +48 +20%
Northern Trust
18
Northern Trust
Illinois
$148K -$4.77K -8 -3%
Walleye Trading
19
Walleye Trading
New York
$140K +$23.9K +40 +19%
U
20
UBS
Switzerland
$83K +$89.5K +150 New
Bank of New York Mellon
21
Bank of New York Mellon
New York
$78K -$2.39K -4 -3%
Renaissance Technologies
22
Renaissance Technologies
New York
$75K -$211K -353 -72%
Jacobs Levy Equity Management
23
Jacobs Levy Equity Management
New Jersey
$61K -$18.5K -31 -22%
Morgan Stanley
24
Morgan Stanley
New York
$56K +$25.1K +42 +72%
GC
25
Guggenheim Capital
Illinois
$43K +$2.98K +5 +7%
1
2

ALT Hedge Fund Activity: Q4 2013 in Review

37 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q4 2013, worth a combined $37M — down 7.3% from $39.9M a quarter earlier.

Fund positioning in ALT was balanced in Q4 2013: 5 funds opened new positions, 5 closed out, 9 added to existing stakes and 9 trimmed.

The largest buyer was Jet Capital Investors, adding an estimated $421K. The largest seller was Deutsche Bank, exiting entirely with an estimated $280K sold.

  • 37 institutional investors held Altimmune (ALT) as of Q4 2013, unchanged from Q3 2013.
  • Funds reported $37M of Altimmune stock for Q4 2013, down 7.3% quarter-over-quarter.
  • 5 funds opened new Altimmune positions in Q4 2013 and 5 closed out, a net change of 0 holders.
  • The largest Altimmune buyer in Q4 2013 was Jet Capital Investors, an estimated $421K added.
  • The largest Altimmune seller in Q4 2013 was Deutsche Bank, an estimated $280K sold.

Based on aggregated 13F filings for Q4 2013.